Dr. Murahari Revanth Kumar

Dr. Revanth is an experienced Nuclear Medicine Specialist with over 8 years of expertise in advanced molecular imaging and radionuclide therapy. He has trained at some of India's leading institutions, including KEM Hospital, Tata Memorial Hospital, and the Radiation Medicine Centre, Mumbai. He specializes in the diagnosis and treatment of cancer, thyroid disorders, and other complex diseases using state-of-the-art nuclear medicine techniques. His expertise includes advanced imaging with PET/CT and SPECT/CT, helping provide accurate diagnosis, disease staging, and treatment monitoring. Dr. Revanth has a special interest in theranostics—a personalized approach that combines targeted imaging and therapy for cancer patients. He is highly skilled in administering Radioactive Iodine (RAI) therapy for thyroid cancer and hyperthyroidism, as well as advanced radionuclide therapies such as Lutetium-177 PRRT, Lutetium-177 PSMA, and I-131 MIBG therapy. Areas of Expertise Diagnostic Nuclear Medicine PET/CT and SPECT/CT Imaging Cancer Imaging and Theranostics Thyroid Cancer Management Radioactive Iodine (RAI) Therapy Hyperthyroidism Treatment Lutetium-177 PRRT Therapy Lutetium-177 PSMA Therapy I-131 MIBG Therapy Neuroendocrine Tumor Imaging and Therapy Prostate Cancer Imaging and Therapy Advanced PET Tracer Studies Professional Experience Dr. Revanth has served as Consultant Nuclear Medicine Specialist at leading cancer and diagnostic centers across India, including Barpeta Cancer Centre (Assam), Prathima Cancer Institute (Telangana), Sprint Diagnostics, and American Oncology Institute, Imphal. He has also worked as Senior Resident in Nuclear Medicine at Safdarjung Hospital and Delhi State Cancer Institute, New Delhi. Patient Care Philosophy Dr. Revanth is committed to delivering precise, evidence-based, and patient-centered care through advanced molecular imaging and targeted radionuclide therapies. His goal is to provide accurate diagnoses and personalized treatment plans